• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

  • HOME
  • Browse articles
  • Previous issues
12
results for

Previous issues

Filter

Article category

Keywords

Authors

Previous issues

Prev issue Next issue

Volume 37(1); March 2014

Review Articles

[English]
Current Evidence for the Treatment of Bladder Cancer
Kwang Hyun Kim, Young Yo Park
Ewha Med J 2014;37(1):1-9.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.1

Bladder cancer is the second most common malignancy in urological field. Most new cases are diagnosed as non-muscle invasive bladder cancer (NMIBC), which includes Ta, T1 or carcinoma in situ. Initial management of NMIBC is endoscopic resection, which allows both treatment and pathological staging. Urologist should consider adjuvant intravesical chemotherapy or Bacillus Calmette-Guerin (BCG) immunotherapy, depending on the tumor grade or stage to prevent recurrence and progression. Patients with muscle invasive bladder cancer (MIBC) are best treated with radical cystectomy. However, radical cystectomy should be considered even in patients with NMIBC with high risk of progression and BCG refractory tumors. Delay of radical cystectomy in these patients might lead decreased disease specific survival. Patients treated by radical cystectomy should undergo any form of the urinary diversion. Ileal conduit is still most common method for urinary diversion. Orthotopic neobladder is generally performed by experienced hands in high volume center. Patients undergoing orthotopic neobladder should be educated and manually skillful to manipulate their diversion. Neoadjuvant cisplatin-based chemotherapy is recommended based on level 1 evidence with survival benefit. Recent updated meta-analysis also demonstrated survival benefit in patients with MIBC treated by adjuvant chemotherapy.

Citations

Citations to this article as recorded by  
  • Clinical Study for the One Case that Sequela of Bladder Cancer Patient Treatments by Korean Medicine
    Seong-Hee Cho, Yu-Rim Song
    The Journal of Oriental Obstetrics and Gynecology.2015; 28(2): 156.     CrossRef
  • 58 View
  • 0 Download
  • 1 Crossref
[English]
Robot-Assisted Laparoscopic Radical Cystectomy
Kwang Hyun Kim, Dong Hyeon Lee
Ewha Med J 2014;37(1):10-15.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.10

Robot-assisted laparoscopic radical cystectomy (RARC) for the treatment of muscle invasive bladder cancer is being increasingly applied. Radical cystectomy is complex procedure which should be performed with extensive lymph node dissection and urinary diversion. Currently, the techniques of RARC are well-described, and the feasibility and safety of RARC has been demonstrated. While extracorporeal approach is preferred method for urinary diversion, intracorporeal urinary diversion is gaining popularity. Positive surgical margins are similar to large open series but inferior for locally advanced disease. However, local recurrence and survival rates seem equivalent to open series at short and mid-term follow up. Randomized controlled trial should be conducted to rigorously assess the oncologic outcomes of RARC compared to open radical cystectomy.

  • 30 View
  • 0 Download
[English]
Renal Cell Neoplasms: Recent Advances
Sanghui Park, Jae Y. Ro
Ewha Med J 2014;37(1):16-25.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.16

The incidence of renal cell neoplasms has been increased in worldwide as well as in Korea. Even though the World Health Organization (WHO) Classification of renal tumors (2004) is currently used, new entities require to be added in the updated classification because of recent modification with our understanding of the molecular biology and different clinical behavior of new renal tumors. In this review, recently described tumors and candidate entities will be discussed. It is of importance to know these new entities for the proper diagnosis, treatment, and their prognosis.

  • 49 View
  • 0 Download

Original Articles

[English]
The Trend of First-Line and Second-Line Eradication Rates for Helicobacter pylori Infection in a Single Institute in Seoul
Mi Yeon Kim, Ki-Nam Shim, Hye-In Kim, Hyeon Ju Kang, Min Sun Ryu, So-Young Ahn, Hye Kyung Jung, Sung-Ae Jung
Ewha Med J 2014;37(1):26-29.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.26
Objectives

To investigate the rate of first-line eradication and the rate of second-line eradication of Helicobacter pylori (H. pylori) from 2001 to 2010 in a single institute in Seoul.

Methods

Among the 2,717 patients who received H. pylori eradication treatment from 2001 to 2010 at Ewha Womans University Mokdong Hospital, the medical records of 1,466 patients who satisfied the condition of execution of upper gastrointestinal endoscopy, positive H. pylori eradication results at 6~8 weeks after eradication therapy were reviewed retrospectively. Then the first-line and second-line eradication rates and the eradication rates according to endoscopy findings were also compared.

Results

The first-line eradication rate was 77% H. pylori eradication rate for the last 5 years was continuously increasing and no sign of decline was observed even for the whole 10 years. The rates of eradication related to endoscopic findings showed statistical significance (P<0.001) of 79.8% and 70.1% each for peptic ulcer and non-ulcerative gastric diseases, respectively.

Conclusion

In this study, no decrease in tendency of first-line eradication rate could be found. In addition, the patients with the non-ulcerative gastric disease seemed to show significantly lower eradication rate. This finding suggests eradication treatment may be affected by the category of gastric diseases, and careful considerations should be taken assessing the effects and needs for the H. pylori eradication treatment.

Citations

Citations to this article as recorded by  
  • Eradication Rates of First-line and Second-line Therapy forHelicobacter pyloriInfection in Gyeongnam Province
    Gyo Hui Kim, Jin Ah Kim, Ui Won Ko, Jong Ho Park, Jue Yong Lee, Su Sin Jin, Yeon-Ho Joo, Jae Uk Shin
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(3): 160.     CrossRef
  • 37 View
  • 0 Download
  • 1 Crossref
[English]
Prevalence of BRAF and NRAS Mutations and a Comparative Analysis in Primary and Metastatic Melanoma of Korean Patients
Deok Young Choi, Sang Pyo Lee, Sanghui Park
Ewha Med J 2014;37(1):30-35.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.30
Objectives

The aim of this study is to verify the status and the clinical significance of BRAF and NRAS mutations in patients of one of the university hospitals in Korea.

Methods

Polymerase chain reaction (PCR) amplification and direct sequencing were performed for the analysis of melanoma samples (n=22) for the detection of mutations in exon 15 of the BRAF gene, and exons 2 and 3 of the NRAS gene in genomic DNA. Mutations of the BRAF gene were correlated with the clinicopathologic features of patients and the BRAF mutation status was compared in 18 paired primary and metastatic tumors.

Results

Incidence of somatic mutations within the BRAF and NRAS genes was 27.3% (6/22) and 0% (0/22), respectively. Age, gender, Breslow thickness, and ulceration did not show correlation with BRAF mutations. Among 18 patients with metastasis, BRAF mutation was detected in 22.2% of cases (4/18), and all four cases with BRAF mutations were identified in metastatic lymph node tissues. BRAF mutations were only found in lymph node metastases, which was statistically significant (28.6% vs 0%, P<0.01).

Conclusion

The incidence of BRAF mutation is as low as in other Asian reports and the NRAS mutation was not found in patients of our institute.

Citations

Citations to this article as recorded by  
  • Survival rates for invasive cutaneous malignant melanoma in South Korea in accordance with the Eighth edition AJCC Cancer Staging Manual: A retrospective single center study
    Seon Hwa Lee, Gi Ung Ha, Hyun Ji Lee, Ho Yun Chung, Seung Huh, Dae-Lyong Ha, Kyung Duck Park, Yong Hyun Jang, Weon Ju Lee, Seok-Jong Lee, Jun Young Kim
    Indian Journal of Dermatology, Venereology and Leprology.2023; 90: 163.     CrossRef
  • The frequency and clinicopathological significance of NRAS mutations in primary cutaneous nodular melanoma in Indonesia
    Hanggoro Tri Rinonce, Deflen Jumatul Sastri, Fita Trisnawati, Bidari Kameswari, Paranita Ferronika, Irianiwati
    Cancer Reports.2022;[Epub]     CrossRef
  • Concordance of somatic mutation profiles (BRAF, NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples
    Shi Yang, Dominick A. Leone, Asok Biswas, April Deng, Drazen Jukic, Rajendra Singh, Uma Sundram, Meera Mahalingam
    Human Pathology.2018; 82: 206.     CrossRef
  • 58 View
  • 0 Download
  • 3 Crossref
[English]
Retrospective Analysis of Anesthesia for Cesarean Section of the Patients with Hypertensive Disorders in Pregnancy for 15 Years
Su Yeon Lee, Eun Chi Bang, Eun Ah Yang, Hyun Sook Lee, Yong In Kang, Kyung Sook Cho, Su Yeon Kim
Ewha Med J 2014;37(1):36-40.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.36
Objectives

To compare the clnical data of general and regional anesthesia for cesarean section in patients with systemic hypertension.

Methods

We conducted a retrospective survey with the medical records of the patients with hypertensive disorders in pregnancy, who under went cesarean section from January 1998 to December 2012. We collected data including patients' demographics, anesthesia and maternal and neonatal outcome. According to anesthetic method, the subjects were divided into general anesthesia and regional anesthesia group and the clinical outcome were compared. We reclassified the patients according to the use of magnesium sul fate (MgSO4) and compared the clinical outcomes.

Results

Of the 1,050 hypertensive parturients, 848 (80.8%) patients went through cesarean section. Three hundred and sixty three patients (42.8%) underwent epidural anesthesia, general and spinal anesthesia were used in 268 (31.6%), and 217 (25.6%) patients, respectively. There was no significant difference in maternal and neonatal outcome according to anesthetic method. In the patients administered MgSO4, 1 minute Apgar score was lower and maternal gestational age and birth weight were less than the patients not receiving MgSO4.

Conclusion

Anesthetic methods did not have effect on outcome of cesarean section of the patients with hypertensive disorder of pregnancy.

Citations

Citations to this article as recorded by  
  • Die neue S1-Leitlinie „Geburtshilfliche Analgesie und Anästhesie“ – Vorstellung und Kommentar
    Dorothee H. Bremerich, Susanne Greve
    Der Anaesthesist.2021; 70(3): 229.     CrossRef
  • 65 View
  • 0 Download
  • 1 Crossref
Case Reports
[English]
Vertebral Artery Dissection Presented with Monoplegia by Cervical Radiculopathy
Sung-Hee Kim, Ji Young Yun, Kee Duk Park, Jee Hyang Jeong
Ewha Med J 2014;37(1):41-45.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.41

Vertebral artery dissection (VAD) is one of important causes of posterior circulation strokes in young age patients. Typical presentations of VAD are occipital headache or posterior neck pain, with various signs arising from brainstem or cerebellar infarctions. Muscular weakness or sensory change of an ipsilateral arm owing to cervical nerve root involvement in association with the VAD has been reported very rarely. Herein we describe two unusual manifestations of extracranial VAD, which presented with monoplegia of single upper limb.

  • 55 View
  • 1 Download
[English]
A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement
Min Hwan Kim, Yehyun Park, Hye Jung Park, Ah-young Ji, Changho Song, Moo-Nyun Jin, Young Ju Kim, Sun Wook Kim, Jung-Hee Lee, In-Soo Kim, Hye Ryun Kim, Joohang Kim, Byoung Chul Cho
Ewha Med J 2014;37(1):46-51.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.46

The rearrangement of c-ros oncogene 1 (ROS1) has been recently identified as an important molecular target in non small cell lung cancer (NSCLC). ROS1 rearrangement and epidermal growth factor receptor (EGFR) mutation were mutually exclusive each other in previous studies, and the clinical implication of co-existence of the two genetic alterations has not been determined. We report a case of 46-year-old female never-smoker NSCLC patient whose tumor harbored ROS1 rearrangement and EGFR mutation concomitantly. She had undergone curative surgery for stage IIIA NSCLC, and the recurrence in left pleura and brain occurred at 2 years after the surgery. She received several lines of chemotherapy including docetaxel plus carboplatin, erlotinib, pemetrexed, and gemcitabine. Erlotinib therapy showed a favorable treatment response with progression-free survival of 9.5 months and partial response of tumor on radiologic evaluations. This case represents a successful erlotinib treatment in a NSCLC patient with concurrent ROS1 rearrangement and EGFR mutation.

  • 30 View
  • 0 Download
[English]
Toxic Megacolon Associated with Secondary Amyloidosis: An Unusual Complication of Clostridium difficile Colitis
Hyung-Won Cho, Hye-Kyung Jung, Hyeon-Ju Kang, Yoon-Pyo Lee, Hye-Won Kang, Ki-Nam Shim, Sung-Ae Jung
Ewha Med J 2014;37(1):52-55.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.52

Amyloidosis is characterized by extracellular deposition of protein fibrils in one or multiple organs. AA amyloidosis is secondarily occurred to be related with chronic infections or inflammatory diseases. We report a 67-year-old man suffered from secondary AA amyloidosis related with chronic Clostridium difficile colitis after repeated total hip replacement surgery. Infection control is the most important treatment of AA amyloidosis secondary to chronic infection. However, the patient's C. difficile colitis was not controlled well, eventually toxic megacolon with sepsis was developed. Consequently, he had to take total colectomy, but he expired with multi-organ failures. We suggested that early surgical procedure might be one option for intractable C. difficile colitis complicated with secondary amyloidosis.

  • 37 View
  • 0 Download
[English]
Coronary Spastic Angina and Life Threatening Arrhythmia despite Nitroglycerine Infusion
Kyoung Hwang Shin, Woo Hee Cho, Do Hyun Lee, Sora Lee, Seong-Hoon Lim
Ewha Med J 2014;37(1):56-59.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.56

Variant angina pectoris is characterized by chest symptoms at rest and transient ST elevation on the electrocardiography due to coronary artery spasm. Although most patients with coronary spasm respond well to medical treatment with vasodilators such as calcium channel blockers and nitrates, some patients show intractable attack of coronary vasospasm despite standard medical therapy. We experienced 50-year-old woman with intractable chest pain due to coronary artery spasm, who suffered from ventricular fibrillation despite continuous intravenous nitrate therapy.

  • 38 View
  • 0 Download
[English]
Chelidonium majus-Induced Acute Hepatitis
Sung Gyu Im, Sun Hong Yoo, Dong Ok Jeon, Hyo Jin Cho, Jin Young Choi, Soya Paik, Young Min Park
Ewha Med J 2014;37(1):60-63.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.60

The use of traditional folk remedies is increasing throughout Asia. Chelidonium majus, a popular herbal remedy, is used to treat abdominal pain caused by various gastrointestinal disorders, including gastric ulcer, gastritis, and biliary tract disease, because of its morphine-like effect. We encountered a 62-year-old woman with acute hepatitis, in which C. majus was suspected to be the etiological factor. The patient had taken high dose of C. majus extract for the preceding 60 days. The clinical context and the temporal association between the start of the herbal medicine treatment and her liver injury allowed us to attribute a causative role to C. majus. The diagnosis was confirmed by liver biopsy and the Council for International Organizations of Medical Sciences/Roussel Uclaf Causality Assessment Method (CIOMS/RUCAM) scale. After C. majus was discontinued, the liver function was restored to normal. In conclusion, because the use of phytotherapy is increasing, we wish to raise awareness of the potential adverse effects of C. majus.

Citations

Citations to this article as recorded by  
  • A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L.: Report of Two Cases of Herb-Induced Liver Injury and Literature Review
    Vera Ciornolutchii, Abdulrahman Ismaiel, Cristina Maria Sabo, Nadim Al Hajjar, Andrada Seicean, Dan L. Dumitrascu
    American Journal of Therapeutics.2024; 31(4): e382.     CrossRef
  • Traditionally Used Medicinal Plants of Armenia
    Arpine Ayvazyan, Christian Zidorn
    Plants.2024; 13(23): 3411.     CrossRef
  • Ethnobotanical Knowledge in Sete Cidades, Azores Archipelago: First Ethnomedicinal Report
    Pedro T. M. Silva, Marta A. F. Silva, Luís Silva, Ana M. L. Seca
    Plants.2019; 8(8): 256.     CrossRef
  • Total Synthesis of the Proposed Structure of Turkiyenine
    Hisataka Kobayashi, Yusuke Sasano, Naoki Kanoh, Eunsang Kwon, Yoshiharu Iwabuchi
    European Journal of Organic Chemistry.2016; 2016(2): 270.     CrossRef
  • RUCAM in Drug and Herb Induced Liver Injury: The Update
    Gaby Danan, Rolf Teschke
    International Journal of Molecular Sciences.2015; 17(1): 14.     CrossRef
  • Chelidonium majus

    Reactions Weekly.2014; 1508(1): 12.     CrossRef
  • 75 View
  • 0 Download
  • 6 Crossref
[English]
Aortic Valve Replacement after Previous Coronary Artery Bypass Grafting with Patent Internal Mammary Artery
Moo-Nyun Jin, Sun Wook Kim, Young Ju Kim, Hyun Ju Kim, Jung-Hee Lee, Myeong-Ki Hong, Byung-Chul Chang
Ewha Med J 2014;37(1):64-67.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.64

With the aging population, more patients who have undergone previous coronary artery bypass grafting (CABG) are surviving long enough to require subsequent aortic valve replacement (AVR). Conventional redo AVR after prior CABG involves resternotomy, dissection and clamping of the patent bypass graft vessel. Favorable results have been reported for AVR following previous CABG; however, the problems of this procedure includes that injury to the patent bypass grafts can result in catastrophic complications. Increasing patient age and comorbidities may increase operative mortality, less invasive percutaneous aortic valve intervention has advanced. However, because there are no sufficient data comparing transcatheter aortic valve intervention with surgical AVR, currently, the surgical approach should still be consider as the standard of treatment for AVR following previous CABG. We report a patient in whom successful conventional AVR was underwent after previous CABG with patent left internal mammary artery.

  • 27 View
  • 0 Download
TOP